Skip to Content Skip to Content

Genetics

New spinal muscle atrophy treatment gains approval
genetic sequence

New spinal muscle atrophy treatment gains approval

Zolgensma is based on a delivery system discovered by a Penn gene therapy pioneer, marking a new milestone in treating the rare disease.

Penn Today Staff

Researchers use gene editing with CRISPR to treat lethal lung diseases before birth
CRISPR-edited lung cells (green) with EGFP fluorescent protein.

CRISPR-edited lung cells (green) with EGFP fluorescent protein. Many, but not all, are alveolar type 2 cells, the target cell type for STM study. (Image: Ed Morrisey, Penn Medicine)

Researchers use gene editing with CRISPR to treat lethal lung diseases before birth

Using CRISPR gene editing, a team from Penn Medicine and Children’s Hospital of Philadelphia have thwarted a lethal lung disease, in which a harmful mutation causes death within hours after birth.

Penn Today Staff

Three from Penn elected to the American Academy of Arts and Sciences
Anita Allen, Daniel Rader, and Zeid Ra'ad Al Hussein

Penn's Anita L. Allen, Daniel J. Rader, and Zeid Ra'ad Al Hussein are among more than 200 newly elected members of the American Academy of Arts and Sciences.

Three from Penn elected to the American Academy of Arts and Sciences

Vice Provost for Faculty Anita Allen of the Law School and the School of Arts and Sciences, Daniel Rader of the Perelman School of Medicine, and Zeid Ra’ad Al Hussein of Perry World House join a group recognized for their world-class leadership and expertise.

Katherine Unger Baillie

Unlocking the female bias in lupus
Microscopic images of cells are blue with diffuse splotches of pink on each cell.

Unlocking the female bias in lupus

The majority of lupus patients are female, and new findings from Montserrat Anguera of the School of Veterinary Medicine and colleagues shed light on why. The research suggests that female lupus patients don’t fully silence their second X chromosome in T cells, leading to an immune response gone awry.

Katherine Unger Baillie

Western bias in human genetic studies is ‘both scientifically damaging and unfair’
A large group of people sit on the ground outside, roughly in a circle around a group of presenters in the African landscape.

Including underrepresented groups in genomics studies, as Sarah Tishkoff (addressing participants above) has done through her career of studying African population diversity, is essential to reap the benefits of such studies, according to a new commentary in the journal Cell. (Credit: Tishkoff lab)

Western bias in human genetic studies is ‘both scientifically damaging and unfair’

In a commentary in the journal Cell, PIK Professor Sarah Tishkoff and Giorgio Sirugo shine a light on the lack of ethnic diversity represented in genomic studies, and the consequences for health and medicine.

Katherine Unger Baillie , Karen Kreeger

Genetic research has a white bias, and it may be hurting everyone’s health

Genetic research has a white bias, and it may be hurting everyone’s health

PIK Professor Sarah Tishkoff and Giorgio Sirugo of the Perelman School of Medicine collaborated on a paper that concluded that predominately European genetic databases may lead to difficulties treating people from other racial backgrounds. “If we don’t include ethnically diverse populations, we are potentially going to be exacerbating health inequalities,” said Tishkoff.